4
Changes in Ownership
CERENOME, INC. Filed Acc 0001209191-17-019941
Options or other derivatives
- VP and GM Cell Therapy acquired 42,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
HARRIS JOHN DAVID · VP and GM Cell Therapy
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-03-08 | Grant or award : show line 1 in the form Incentive Stock Option (right to buy) | +42,000 | 42,000 | D |
Loading xslF345X03/doc4.xml…